Skip to main content
Access Resources

MJFF Publications

991 - 1000 of 7540 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • RESTRICTED
    Title: Chemical Replacement of Noggin with Dorsomorphin Homolog 1 for Cost-Effective Direct Neuronal Conversion
    Journal Name: Cellular Reprogramming
    Publisher: Mary Ann Liebert Inc
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1089/cell.2021.0200
    Citation Count: 0
  • RESTRICTED
    Title: Clinicopathologic Correlations of Jaw Tremor in a Longitudinal Aging Study
    Journal Name: Neurology Clinical Practice
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/cpj.0000000000200072
    Citation Count: 0
  • RESTRICTED
    Title: Concerns about the European Academy's Recommendations and Guidelines Regarding Pallidotomy for Parkinson's Disease
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/ene.15569
    Citation Count: 3
  • RESTRICTED
    Title: Delivery of RNA Therapeutics: The Great Endosomal Escape!
    Journal Name: Nucleic Acid Therapeutics
    Publisher: Mary Ann Liebert Inc
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1089/nat.2022.0004
    Citation Count: 32
  • RESTRICTED
    Title: Diagnosis and Medical Management of Parkinson Disease
    Journal Name: CONTINUUM: Lifelong Learning in Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/con.0000000000001152
    Best OA location URL:
    Citation Count: 1
  • RESTRICTED
    Title: Diagnosis and Treatment of Cognitive and Neuropsychiatric Symptoms in Parkinson Disease and Dementia With Lewy Bodies
    Journal Name: CONTINUUM: Lifelong Learning in Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/con.0000000000001151
    Best OA location URL:
    Citation Count: 4
  • RESTRICTED
    Title: ECTRIMS 2022 – Poster
    Journal Name: Multiple Sclerosis Journal
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1177/13524585221123687
    Citation Count: 13
  • RESTRICTED
    Title: Emerging therapeutic developments in neurodegenerative diseases: A clinical investigation
    Journal Name: Drug Discovery Today
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.drudis.2022.06.005
    Best OA location URL:
    Citation Count: 9
  • RESTRICTED
    Title: FDG-PET combined with learning vector quantization allows classification of neurodegenerative diseases and reveals the trajectory of idiopathic REM sleep behavior disorder
    Journal Name: Computer Methods and Programs in Biomedicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.cmpb.2022.107042
    Citation Count: 12
  • RESTRICTED
    Title: Global, in situ analysis of the structural proteome in individuals with Parkinson’s disease to identify a new class of biomarker
    Journal Name: Nature Structural & Molecular Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41594-022-00837-0
    Best OA location URL:
    Citation Count: 16
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.